MENU
+Compare
KYMR
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$36.81
Change
-$0.61 (-1.63%)
Capitalization
2.38B

KYMR Kymera Therapeutics Forecast, Technical & Fundamental Analysis

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KYMR with price predictions
Feb 18, 2025

KYMR's RSI Oscillator recovers from oversold territory

The RSI Indicator for KYMR moved out of oversold territory on February 12, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In of the 23 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where KYMR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KYMR advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on KYMR as a result. In of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KYMR turned negative on January 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

KYMR moved below its 50-day moving average on January 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for KYMR moved below the 200-day moving average on February 11, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KYMR entered a downward trend on January 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.670) is normal, around the industry mean (12.604). P/E Ratio (0.000) is within average values for comparable stocks, (85.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.581). KYMR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (29.240) is also within normal values, averaging (252.111).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KYMR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KYMR is expected to report earnings to fall 5.98% to -77 cents per share on February 20

Kymera Therapeutics KYMR Stock Earnings Reports
Q4'24
Est.
$-0.77
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.10
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.15
The last earnings report on October 31 showed earnings per share of -81 cents, beating the estimate of -82 cents. With 397.35K shares outstanding, the current market capitalization sits at 2.38B.
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
200 Arsenal Yards Boulevard
Phone
+1 857 285-5300
Employees
187
Web
https://www.kymeratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

KYMR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.68%
CCCC - KYMR
61%
Loosely correlated
-6.60%
ERAS - KYMR
48%
Loosely correlated
-1.27%
RYTM - KYMR
47%
Loosely correlated
+1.52%
XENE - KYMR
47%
Loosely correlated
+0.62%
ACLX - KYMR
47%
Loosely correlated
-1.49%
More